Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Th2‐mediated anti‐tumour immunity: friend or foe?

Open access
Ellyard, J. I., Simson, L., Parish, C. R. · 2007 · Tissue Antigens

Abstract

The concept that the immune system can recognise tumour cells and either eliminate them (tumour immune surveillance) or select for immunologically resistant variants (immunoediting) is gaining general acceptance by immunologists. In terms of an adaptive immune response to cancer, however, much of the research has focused on the response of cytotoxic CD8+ T lymphocytes to tumour‐specific antigens and the production of Th1 cytokines by CD4+ and CD8+ T cells. In contrast, Th2‐mediated immunity has traditionally been viewed as favouring tumour growth, both by promoting angiogenesis and by inhibiting cell‐mediated immunity and subsequent tumour cell killing. While there is evidence that components of type 2 inflammation, such as B cells and interleukin‐10, do promote tumour growth, there are also many studies demonstrating the anti‐tumour activity of CD4+ Th2 cells, particularly in collaboration with tumour‐infiltrating granulocytes, such as eosinophils. In this review, we examine all the components of type 2 immunity and their effects on tumour growth. Collectively, from this analysis, we conclude that there is a great potential for the development of Th2‐mediated immunotherapies that harness the cytotoxic activity of eosinophils.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-0039.2007.00869.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 207

Metadata

Authors
Ellyard, J. I., Simson, L., & Parish, C. R.
Venue
Tissue Antigens
Publisher
Wiley
Published
2007-06-06
Volume
70
Issue
1
Pages
1-11
ISSN
  • 0001-2815 (ISSN-L)
  • 1399-0039
OpenAlex
W2081272311
Cited by
207
References
6
FWCI
4.68
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Th2‐mediated anti‐tumour immunity: friend or foe? https://app.cochat.ai/papers/10.1111/j.1399-0039.2007.00869.x
The paper
Ellyard, J. I., Simson, L., & Parish, C. R. (2007). Th2‐mediated anti‐tumour immunity: friend or foe? Tissue Antigens. https://doi.org/10.1111/j.1399-0039.2007.00869.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.